Anxiety & InsomniašŸ«£šŸ’¤ Flashcards

(31 cards)

1
Q

Psychological anxiety symptoms

A

Worrying thoughts, hard to control
Fearful anticipation
Poor memory
Insomnia
Poor concentration
Avoidance behaviours
Irritability
Sensitivity to noise and light

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Physical anxiety symptoms

A

Palpitations, SOB
Tremor
Sexual difficulties
Problems with urinary/faecal excretion
Fatigue
Dizziness, headache
Poor swallowing / dry mouth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name 3 types of anxiety disorders

A

Generalised anxiety disorder (GAD)

Panic disorder

Social phobia/ social anxiety disorder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Anxiety diagnosis

A

Differential diagnosis
Duration of symptoms and severity determines whether it is anxiety

General screening: GAD-2 (generalised anxiety scale) to see if further investigation is required.

GAD-2 questions: how often have you experienced the following over the last 2 weeks?
Feeling nervous / anxious/ on edge
Uncontrollable worrying

3+ = GAD-7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Generalised anxiety disorder (GAD) diagnosis

A

Specific symptoms:
Excessive worry about a number of issues most of the time (not restricted to specific issue)
Preoccupation/seeking reassurance for somatic symptoms or chronic physical health problem
Over arousal and irritability
Insomnia and poor concentration

Duration: 6 months +

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Panic disorder diagnosis

A

Specific symptoms:
Worrying thoughts and fearful anticipation
Unforeseen abrupt surge of intense fear (panic attack)
Poor memory

Duration: Panic attack followed by one month of persistent worry about recurrence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Social anxiety / phobia disorder diagnosis

A

Specific symptoms:
Persistent and overwhelming fear of social situations that is out of proportion
Excessive worrying before, during and after

Duration: 6 months +

Mini social phobia inventory screening

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

GAD treatment

A

Psychological:
First line: psychological but may need pharmacological if more severe/ big impact
1) Education + active monitoring
2) Self-help (non-facilitated or guided eg appointments) + group education (if education didn’t work)
3) high intensity psychological intervention. CBT. Applied relaxation (last option if others not worked / marked functional impairment (moderate-severe)

Pharmacological therapy:
Offered to those who have marked functional impairment or education/self-help not effective (moderate-severe severity)
Treatment choice:
• Selective Serotonin Reuptake Inhibitor (SSRI)
first line - sertraline (unlicensed)
Response increases over time
If effective treat for one year

Alternative SSRI or SNRI second line

Offer pregabalin 3rd line

Benzodiazepines for short term use only in severe anxiety state (crisis)

DO NOT use antipsychotic

Shared decision

Anxiolytics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Panic disorder treatment

A

Psychological therapy
Offer individualised cognitive behavioural therapy (CBT)
- Over 1-2 hours for each weekly session
- Max 4 months of treatment

Facilitated or non-facilitated self help materials - groups and exercise

If not effective, add in pharmacotherapy

Pharmacological therapy
Less evidence of longer duration of positive effects than CBT
Consider OD/harm risk, patient
preference/history/co-morbidities/other meds

Treatment choice:
-Selective Serotonin Reuptake Inhibitor (SSRI)
first line - any licensed for panic disorder eg peroxitine, sertraline, citalopram

Second line - use imipramine or clomipramine (tricyclic antidepressants)

Give up to 12 weeks to see if medication working but see patient every two weeks for updates

-If treatment successfully used for 6 months dose can be tapered and stopped

-DO NOT use benzodiazepines (BZDs), antipsychotics, sedating antihistamines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Social anxiety / phobia disorder treatment

A

Psychological therapy
Offer individualised cognitive behavioural therapy (CBT)(workbook and activities with counsellor)
- Clark and Wells model (education and video feedback to build self esteem )
- Heimberg model (exposure therapy)

Those who decline CBT may be offered CBT-based self help

Combine CBT with pharmacological approaches if partial/limited response

Psychodynamic therapy last line

Pharmacological therapy
Offered to those who:
Partially respond to CBT
Do not want psychological therapy

Treatment choice:
Selective Serotonin Reuptake Inhibitor (SSRI)
first line - sertraline/escitalopram (10-12 weeks for full effect)

Alternative SSRI or SNRI second line - venlafaxine/fluvoxamine/ peroxitine

Mono-amine oxidase inhibitor (MAOl) 3d line - moclobemide/phenelzine

DO NOT use benzodiazepines (BZDs), tri-cyclic antidepressants (TCAs), antipsychotics, St John’s
Wort or anticonvulsants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Considerations for antidepressants on anxiety disorders

A

• Treatment may take 2 weeks or more to work - short term treatment with benzodiazepines may be required

• Important ADRs (side-effects) for antidepressants are anxiety, Gl disturbances, anorexia, insomnia, agitation and suicidal thoughts/behaviours

• Careful monitoring for those aged under 30 / prior suicide risks

• Careful with dosing SSRIs in GAD and/or panic disorder (starting doses may be lower than for depression but can go higher)

• Other pharmacological options for anxiety that are not in NICE guidelines
Propranolol for physical symptoms of anxiety, useful in situational stress (no effect on psychological / non-autonomic symptoms) (palpitations/ shortness of breath/ sweating) (treats symptoms not underlying cause)
Buspirone for GAD (5HT1 partial agonist)(short term options for severe anxiety)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Treatment points

A

• Please see lectures from Joanne Nguyen and Mike Harte on antidepressant side effects and important pharmaceutical care considerations across different classes (e.g. hyponatraemia, serotonin syndrome, QT prolongation, risks in cardiac disease)

• Benzodiazepines - see lecture part 3 for risks

• Pregabalin now a schedule 3 controlled drug due to its abuse potential.

• General lifestyle advice: make time for relaxation, try to optimise exercise, alcohol reduction

• Treatment resistance, suicide risk and substance misuse prompt specialist referral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Medicine optimisation in anxiety summary

A

• Rule out other (preventable) causes of anxiety symptoms.

• Non-pharmacological methods usually first line treatment for anxiety

• Tailor drug treatment for anxiety to individual patient wishes/history
- SRis main first line drug treatment for moderate-severe anxiety disorders
- Other options: SNRI, TCA, pregabalin, MAOI
- Adjunctive treatments: propranolol, buspirone, others

• Prescribing advice: selecting and initiating antidepressant treatment

• Education: limited role of BZD in anxiety disorders, associated risks and withdrawal regime

• Patient counselling: drug choice, initiation and important side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Insomnia factors

A

Drugs
Life events
The environment
Illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

3 types of insomnia & symptoms

A

Can be transient, acute or chronic insomnia
• Transient - sleep well usually. Jet lag, shift work, noise/light disturbance
• Short term - may last for a few weeks, bereavement, physical illness
ā€¢ā€Chronic insomnia can be defined as an inability to achieve or maintain sleep satisfactorily on the majority of nights (3+ per week) over a period of at least three months, despite adequate opportunity, with subsequent adverse consequences on daily functioningā€

Irritable , cognitively impaired, tired during the day

Sleep condition indicator screening: over the month has sleep troubled you in general? If it has, how many nights per week are you troubled by poor sleep? Very low score can require further investigation

Patients may report one or more of the following:
• Difficulty in falling asleep
• Frequent waking during the night
• Early morning waking
• Daytime sleepiness
• General loss of well-being due to bad night’s sleep

Snoring heavily / frequently and restless legs may be a prompt for referral (sleep apnea)

Consider use of the two item sleep condition indicator for screening in primary care.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Insomnia treatment

A

Hypnotics - BZDs abd ā€˜Z drugs’

Before treatment, consider underlying causes

Drugs only for severe / interfering with daily life

CBTi - sleep restriction and stimulus control. Helps chronic insomnia by discussing patients thoughts and behaviour with sleep.

Sleepio (app)

Sleep hygiene approaches

These help explore sleep habits and patterns.

Hypnotics cannot cure insomnia - treat underlying causes if present

17
Q

Sleep hygiene approaches

A

• Determine whether expectations of sleep are realistic

• Sleep diaries can be helpful - study sleep patterns, wakefulness, lifestyle factor

• Increase daily exercise (not in the evenings/within 4 hours of bedtime)

• Stop daytime naps

• The bedroom should be at the right noise and light levels, at the right temperature

• Reduce consumption of certain substances in the evenings (e.g. food and fluids, alcohol (interferes with REM sleep, more awakening, more time in non REM 1 and 2, less time in slow wave sleep) , chocolate, smoking, avoid caffeine after midday)

• Use the bed only for sleeping/sex, avoid TV/computers/devices in the bedroom

• Use relaxation techniques (e.g. Audio tools, breathing, counting methods)

• Develop a routine for rising and going to bed

• If you cannot sleep after 30 minutes, get up and do something else, then return

• Keep pets that disturb sleep out of the bedroom

18
Q

Sleepio app

A

• Recommended by NICE May 2022 for use instead of sleep hygiene / hypnotics

• Costs Ā£45 currently, NICE says more cost effective than usual treatment

• Involves
- Six week self-help programme, tailored approach, CBTi principles
- Sleep test and diary

• Medical assessment required before use in pregnancy and co-morbidities

• ?Unclear if more effective than CBTi

19
Q

3 insomnia non-drug approaches

A

Sleep hygiene
Sleepio app
CBTi

20
Q

Insomnia drug treatment

A

Consider tolerance and dependence (addiction) (taper down gradually)

• Use pharmacological ā€˜hypnotic’ agents (BZD and Z drugs):
• For the shortest time period (usually 2 weeks, max 4 weeks, see SmPCs)
• For one or two doses, or intermittently if possible
• At the lowest effective dose

• If severe transient/short term insomnia, a few doses may be sufficient

• Additive sedative effects with alcohol (avoid) and other sedating drugs (e.g. clozapine)

• No difference between BZDs and ā€˜Z drug’ hypnotics in terms of efficacy (just side effects and tolerability)

• Prescribe the agent with the lowest acquisition cost

• Could use shorter acting agent if difficulty falling asleep
But increased risk of tolerance/dependence and late night rebound insomnia
Temazepam (Benzodiazepine), Zolpidem (Z drug)

• Could use longer acting agent if frequent and/or early morning wakening
Be mindful of next day sedation and loss of co-ordination (ā€˜hangover’ effect)
Longer acting agents less likely to cause rebound insomnia
Nitrazepam (Benzodiazepine), Zopiclone (Z drug)

• Reduce doses slowly if patients have used hypnotics for a prolonged period

• Monitor carefully for rebound insomnia and withdrawal symptoms

• The risks of treating older people with hypnotics may outweigh the benefits (increases falls risk and hip fracture)

21
Q

Other insomnia drug treatments

A

CBT-I may be better than hypnotics longer term (see directed reading)

• Melatonin
- Mimics natural melatonin: not addictive and well tolerated, does not cause tolerance
- Usual dose 2mg daily, licensed as monotherapy for over 55’s, very short acting (often appears as MR prep) - promotes sleep initiation and uninterrupted sleep

• Sedating antihistamines
- Diphenhydramine, chlorphenamine and promethazine
- Can be purchased OTC, have mild-moderate effects but commonly produce ā€˜hangover’ ADRs and tolerance can develop to effects. Can also produce a ā€˜high’

• Clomethiazole
- Dependence/tolerance and respiratory depression in overdose limit use

• Over the counter (OTC) preparations (avoid)
- Very small evidence base
• Valerian-hops combinations |
• Passion-flower
• Jamaica Dogwood (toxic)

22
Q

Melatonin

A

Can cause toxicity episodes

• Increasing use of melatonin in young people
- Generally high levels of melatonin when younger, falling levels as getting older
- Being driven by increasing diagnosis of certain conditions?

• Perception it is ā€˜safe’ - but lacking long term safety data
- Timing also important
- Parents may be reluctant to stop it once started
- Increasing toxicity episodes in US

• Only likely to be effective in circadian rhythm disorders

• Specific licensing - lots of use outside?
- Short term use
- Adults: jet lag, age 55+, learning difficulties
- Children: Learning difficulties, sleep onset disorder, autism and ADHD

23
Q

Daridorexant

A

For chronic insomnia affecting at least 3 nights per week and lasting at least 3 months, not responding to sleep hygiene and/or CBTi (so it is a second line option)

Orexin antagonist (regulates wakefulness)

Review regularly and stop if not an adequate response

May worsen depression and suicidal ideation, and in other disorders too. Can cause dizziness and drowsiness, hallucinations, sleep paralysis

• Review regularly and stop if not an adequate response, caution in mental illness

24
Q

Medicines optimisation insomnia summary

A

• Try non-pharmacological methods and explore cause(s) first unless severe

• Try to avoid BZD and Z drugs in high risk groups

• Choose hypnotic agents based of half life and symptom presentation

• Enforce practical prescribing of BZD and Z drugs, Daridorexant an option if chronic symptoms

• Patient counselling r.e. appropriateness of BZD and Z drugs for insomnia

• Patient counselling r.e. alternative treatments for insomnia (e.g. OTCs)

• Education r.e. effectiveness & tolerance/dependence with BZD/Z drugs

25
Benzodiazepines & insomnia
• Half-life important in selecting treatment, and in developing risks Shorter half life: lorazepam (10-20), oxazepam (4-15), temazepam (8-22) (most sedating) Longer half life: diazepam (20-100), clonazepam (35), nitrazepam (15-38) • Mechanism of action - see Dr Mike Harte's lectures • Risk of tolerance and dependence, withdrawal reactions greater if shorter half life, higher dose, prolonged use and higher potency - Lorazepam and clonazepam are potent benzodiazepines (tolerance & dependants) • Become more harmful in overdose when taken with other CNS depressants/alcohol/opiods • Plasma levels of BZDs affected by certain CYP3A3/4 enzyme inducers (eg antifungals) and inhibitors (eg microlides) • ADRs sedation/drowsiness (driving), confusion, falls, amnesia, aggression, disinhibition, tolerance, dependence and abuse Patient counselling important: driving/operating machinery, issuing prescriptions - Extreme caution in the elderly, previous addiction • BZDs have been used to treat anxiety for over 40 years - Diazepam, lorazepam, oxazepam, (clonazepam used, not recommended) • NOT recommended for panic disorder or social anxiety disorder, but suitable for GAD crisis • However, some evidence for persistent/severe anxiety in short courses (max. 4 weeks) at lowest effective dose, with some benefiting from long term treatment • Diazepam a suitable choice in anxiety (relatively lower potency = reduced risk of dependence) , avoid lorazepam and clonazepam Disadvantages: May not feel restored / refreshed after Rebound insomnia common: after stopping treatment, insomnia may be worse than before (more difficult getting / staying asleep / waking up early) Risk factors: shorter acting agents, higher doses, prolonged treatment Rebound insomnia can increase the likelihood of drug dependence • BZDs are the most widely prescribed hypnotic agents - temazepam, nitrazepam • Use shorter or longer acting agents depending on symptom presentation - Longer acting increases risk of 'hangover' effect • They can reduce stage 3 and 4 non-REM sleep (slow wave sleep) / nightmares • Extreme caution in the elderly, previous addiction
26
Benzodiazepines tolerance & dependance
• Long term treatment may result in: Tolerance (even after 3-14 days!) Psychological and physical dependence Withdrawal reactions upon treatment cessation (anxiety, depression, flu-like symptoms, nightmares, muscle pain and weakness, poor concentration) • NICE - do not prescribe for more than 1 month • Patient and medication related risk factors eg past drug dependance, higher potency, longer duration of use, short half life, higher dose • Symptoms of dependence mimic overdose: unsteadiness, drowsiness, speech disorder, nystagmus • Withdrawal from BZDs: Successful withdrawal from treatment may take months, especially for long term users Switch patients on short/intermediate acting treatments to diazepam (useful liquid preparation) Reduce dose gradually as abrupt withdrawal can be dangerous, e.g. 10% every 2 weeks Slow withdrawal does not eliminate ADRs - psychological therapy may help - When withdrawal symptoms emerge, slow/halt titration, slight dose increase may be necessary
27
Z drug hypnotics and insomnia
• Zopiclone (longer acting for waking up at night/ early) , Zoplidem (shorter, for when struggling to get to sleep) - little difference in efficacy between 'Z drugs' • Shorten stage 1 sleep, but increase stage 2, little effects on stage 3/4 • Stimulate activity at GABA, receptor in a similar way to BZDs (see Mike Harte's lecture) • Appear just as effective as BZDs, but may also be possible to produce rebound insomnia, tolerance/dependence and neuropsychiatric reactions • Similar cautions to BZD - withdrawal reactions, driving/operating machinery, prescriptions • Need to withdraw gradually if prolonged use • NICE Technology Appraisal TA77 If patients fail to respond to one 'Z drug' do not offer another (same is true for BZDs)
28
Benzodiazepines & Z drugs medicines optimisation points
• Enforce practical prescribing of BZD and Z drugs • Patient counselling r.e. appropriateness of BZD and Z drugs • Patient counselling r.e. alternative treatments • Education r.e. effectiveness & tolerance/dependence with BZD/Z drugs
29
EBL: Specify the class of drugs used to manage symptoms of insomnia and list the pros and cons of using them in insomnia management for Ms HS given her medical history, and any risks to consider. burcu + taybah
available OTC are sedating histamines, such as Diphenhydramine (e.g., Benadryl, Nytol) Promethazine (e.g., Phenergan) These antihistamines cause drowsiness by blocking histamine H1 receptors in the brain, making them effective for short-term sleep aid use. However, they should be used cautiously due to potential side effects like daytime drowsiness, cognitive impairment, and drug interactions. Sedating Antihistamines: Diphenhydramine, promethazine Block histamine (H1) receptors, inducing drowsiness. Pros OTC availability, effective for short-term use, non-habit forming. Cons Tolerance development, daytime drowsiness, cognitive impairment, drug interactions with valproate. Benzodiazepines: Temazepam, Lorazepam, Diazepam Enhance GABA activity, promoting sedation and muscle relaxation. Pros Potent sedative effect, fast-acting, useful for severe insomnia. Cons High risk of dependence, withdrawal effects, increased sedation when combined with valproate, cognitive impairment. Non-Benzodiazepine Z-Drugs Zolpidem, Zopiclone, Eszopiclone Selectively target GABA receptors to induce sleep with less hangover effect. Pros Less daytime drowsiness than benzodiazepines, effective for short-term use. Cons Can still cause dependence, may lead to sleepwalking or memory issues, interactions with CNS depressants. Melatonin Receptor Agonists Melatonin, Ramelteon Regulate circadian rhythm and promote sleep onset. Pros Helps regulate sleep-wake cycle, non-habit forming. Cons Less effective for severe insomnia, potential for dizziness and headache. Antidepressants (Sedating Types) Trazodone, Mirtazapine, Amitriptyline Affect serotonin and histamine receptors, inducing drowsiness. Pros Can be useful for insomnia with depression or anxiety, long duration of action. Cons Weight gain, daytime sedation, drug interactions, risk of worsening cognitive effects when combined with valproate. Risks to consider due to HS background Drug Interaction with Valproate Increased sedation, dizziness, and cognitive impairment with CNS depressants (e.g., benzodiazepines, sedating antihistamines). Higher Risk of Side Effects More pronounced dry mouth, dizziness, and gastrointestinal discomfort. Respiratory Depression Risk CNS depression from sedatives combined with valproate may suppress breathing in rare cases. Liver Metabolism Effects Valproate affects liver enzymes, altering drug metabolism and increasing side effects (especially for sedating antihistamines and some antidepressants). Pregnancy Concerns Valproate is harmful during pregnancy, requiring specialist consultation before considering sleep medications. Additions from EBL: Benzodiazepines Pros Effective for short-term insomnia; Relieves anxiety; Fast onset; Can be highly effective for sleep. Cons Risk of dependence and tolerance; Cognitive impairment; Withdrawal symptoms; Daytime sedation; Increased risk of falls. Non-Benzodiazepines (Z-drugs) Pros Lower risk of dependence than benzodiazepines; Fewer cognitive side effects; Effective for short-term use. Cons Risk of abuse; Unusual sleep behaviors (sleepwalking, etc.); Cognitive and motor side effects; Rebound insomnia. Melatonin Pros Non-habit forming ; Mimics natural sleep-wake cycle; Generally safe; Effective for circadian rhythm issues. Cons Limited effectiveness for chronic insomnia; Not effective for anxiety or stress-related insomnia; Mild side effects.
30
EBL: Compile a set of possible sleeping tablets and identify their chemical structure and name key functional groups. Using a reliable resource, compute the molecular weight, logP, pKa, dominant ionisation state, number of hydrogen bond donors and number of hydrogen bond acceptors in each of them. Compare and contrast them and explain the relevance of any differences.
31
EBL: ongside unmanaged sleep problems and the recent valproate reduction, Ms HS quickly relapses into mania, and is admitted to the acute female mental health ward. She is treated with Olanzapine to manage the acute symptoms of mania until lithium therapy is initiated for the maintenance of bipolar mania symptoms. As the inpatient pharmacist, you have been asked to create a lithium advice sheet detailing the main monitoring and counselling points that would need to be discussed with the patient. l
COUNSELLING POINTS 1.Take at the same time everyday - usually at night 2. Keep hydrated - 6-8 glasses of water daily 3. Maintain consistent salt intake - can affect lithium levels 4. Carry your lithium card! MONITORING REQUIREMENTS • Lithium levels must be checked weekly after starting or changing dose until they're stable. Then must be checked every 3 months to ensure levels remain within therapeutic range (0.4-0.8 mmol/L) • Toxicity risk if levels exceed 1.2 mmol/L • Kidney and thyroid function checked every 6 months • Also —> U&Es, weight, ECG DRUG INTERACTIONS AND LIFESTYLE ADVICE • Avoid NSAIDS, diuretics, ACE-inhibitors, antipsychotics and steroids antidepressants, • Avoid excess alcohol and caffeine • Avoid taking lithium during first trimester as it can cause birth detects • Avoid stopping the medication abruptly - talk with your prescriber first SIGNS OF TOXICITY Contact your doctor immediately if you experience: • severe nausea, vomiting, diarrhoea • blurred vision or difficulty focusing • tremors or muscle weakness • drowsiness, confusion, or siurred speech -›Typcially due to dehydration, overdose or sudden salt intake changes